Influenza Vaccines in the United States by Vaccine Type (Trivalent Vaccines and Quadrivalent Vaccines), by Virus Type (Influenza Virus Type A and Influenza Virus Type B), and by Age Group (Pediatrics and Adults) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2030

pa_user-types

Check Today's Best Price

$3500 Buy Now
The U.S. Influenza Vaccines Market was valued at US$ 2.7 billion in 2019 and is expected to witness a CAGR of 16.3% over the forecast period (2019–2027).
  • United States Influenza Vaccines Market Overview

    The report study researched by Research Industry US gives comprehensive knowledge and valuable insights about the United States Influenza Vaccines Market. Also, the study attempts to deliver significant and detailed insights into the current market prospect and emerging growth scenarios. The report on the United States Influenza Vaccines Market also emphasizes on market players as well as the new entrants in the market landscape.

    The U.S. influenza vaccines market was valued at US$ 2.7 billion in 2019 and is expected to witness a CAGR of 16.3% over the forecast period (2019–2027).

    The United States Influenza Vaccines Market report is a precise and deep-dive study on the current state that aims at the major drivers, market strategies, and imposing growth of the key players. Worldwide U.S Influenza Vaccines Industry also offers a granular study of the dynamics, segmentation, revenue, share forecasts, and allows you to make superior business decisions. The report serves imperative statistics on the market stature of the prominent manufacturers and is an important source of guidance and advice for companies and individuals involved in the U.S Influenza Vaccines industry.

    Impact of Coronavirus (COVID-19) on United States Influenza Vaccines Market.

    Coronavirus (COVID-19) is spreading across the world with a serious impact on the economy and the global market. The report considers and accounts for the impact of COVID-19 on United States Influenza Vaccines Market across all the segments, regions, countries, and key players. North America and Europe are worst-hit countries by Coronavirus which are key players in the global economy. The report provides a detailed analysis of the impact on the market, growth strategies, supply china disruption, consumption pattern of the United States Influenza Vaccines Market.

    Market Segmentation

    The report provides market size with 2019 as the base year in consideration and a yearly forecast until 2030 in terms of Revenue (USD Million). The estimates for all segments including type and application have been provided on a regional basis for the forecast period mentioned above. We have implemented a mix of top-down and bottom-up approaches for market sizing, analyzing the key regional markets, dynamics, and trends for various applications.

    Major and Promising Vaccine covered in the report are as follows:

    1. Fluzone High–Dose
    2. Fluzone Quadrivalent
    3. Intradermal (ID) Trivalent
    4. Vaxigrip
    5. Fluarix Quadrivalent
    6. Flulaval Quadrivalent
    7. Fluenz Tetra
    8. FluMist Quadrivalent
    9. Flublok
    10. VN–100
    11. M–001
    12. VAX–2012Q
    13. TAK – 850
    14. Flucelvax Quadrivalent
    15. Afluria Quadrivalent
    16. Agrippal
    17. Fluad
    18. Fluvirin
    19. Fluvax

    Competitive Landscape:

    Key players profile in the report include

    Sanofi Pasteur
    Seqirus Vaccines Ltd.
    GlaxoSmithKline Plc.
    Medimmune
    VaxInnate
    Mitsubishi Tanabe Pharma
    BiondVax Pharmaceuticals Ltd
    Seqirus
    AstraZenecca
    Protein Sciences Corporation
    Novavax
    Daiichi–Sankyo

    The report of United States Influenza Vaccines Market studies the key players present in the market. The chapter includes the competitive landscape section which provides the full and in-depth analysis of the current market trends, changing technologies, and developments that will be beneficial for the companies, which are competing in the market. The report offers an overview of revenue, demand, and supply of data, futuristic cost, and growth analysis during the projected year. In addition to a brief overview of the company, analysts shed light on their valuation and evolution. It also discusses the list of important products and the ones in the pipeline. The competitive landscape is analyzed by understanding the approaches of the companies and the initiatives they have taken in recent years to triumph over the intensive competition.

    Frequently Asked Questions (FAQ):

    • What is the size of the United States Influenza Vaccines Market?
    • How much will this market be worth from 2020 to 2030?
    • What are the major deals happenings in the United States Influenza Vaccines Market?
    • Which country is expected to hold the highest market share in the United States Influenza Vaccines Market?
    • What are production processes, major issues, and solutions to mitigate the development risk?
    • Who are the top players and what are their activities, revenue, recent developments, and prospects?
    • What are the main drivers and restraints in the United States Influenza Vaccines Market?
    • Which are the largest revenue generating products, services or regions and their comparative growth rate?
    keyboard_arrow_up
  • 1. Executive Summary

    2. United States Influenza Vaccines Market Size & Analysis (2013 – 2030)

    3. United States Number of Persons Vaccinated with Influenza Vaccines (2013 – 2030)
    3.1 Number of Children Vaccinated with Influenza Vaccines
    3.2 Number of Adults Vaccinated with Influenza Vaccines

    4. Key Drivers and Inhibitors of the United States Influenza Vaccines Market
    4.1 Market Drivers
    4.2 Market Inhibitors

    5. United States Influenza Vaccines Pricing Trends & Analysis

    6. United States Influenza Vaccines Production, Supply, and Allocation (By Companies)

    7. United States Influenza Vaccines Distribution & Demand (2010 – 2018)

    8. Effectiveness of Influenza Vaccines in United States (2004 – 2018)

    9. Rapid Diagnostic Testing for the Management of Influenza

    10. Distribution Channel & Technique of Influenza Vaccination in United States

    11. United States Influenza Vaccines Reimbursement Policies & Regulatory System
    11.1 Reimbursement Policies
    11.2 Regulation System

    12. Major Deals in United States Influenza Vaccines Market
    12.1 Merger & Acquisitions
    12.2 Collaboration Deal
    12.3 Licensing Agreement
    12.4 Exclusive Agreement
    12.5 Distribution Agreement

    13. Promising Influenza Vaccines in Clinical Development

    14. Influenza Vaccines Clinical Trial Insights by Phase, Company & Country
    14.1 Year 2018
    14.2 Year 2017

    15. Key Companies Analysis
    15.1 Sanofi Pasteur
    15.1.1 Business Overview
    15.1.2 Influenza Vaccines Portfolio
    15.1.3 Influenza Vaccine Value Sales Analysis
    15.1.4 Recent Development
    15.2 GlaxoSmithKline (GSK)
    15.2.1 Business Overview
    15.2.2 Influenza Vaccines Portfolio
    15.2.3 Influenza Vaccine Sales Value Analysis
    15.2.4 Recent Development
    15.3 Seqirus
    15.3.1 Business Overview
    15.3.2 Influenza Vaccines Portfolios
    15.3.3 Recent Development
    15.4 AstraZeneca
    15.4.1 Business Overview
    15.4.2 Influenza Vaccines Portfolio
    15.4.3 Influenza Vaccine Sales Value Analysis
    15.4.4 Recent Development

    keyboard_arrow_up
  • Key players profile in the report include

    Sanofi Pasteur
    Seqirus Vaccines Ltd.
    GlaxoSmithKline Plc.
    Medimmune
    VaxInnate
    Mitsubishi Tanabe Pharma
    BiondVax Pharmaceuticals Ltd
    Seqirus
    AstraZenecca
    Protein Sciences Corporation
    Novavax
    Daiichi–Sankyo

    keyboard_arrow_up


    • Keep your personal detail safe with us. Privacy Policy
      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

What Information does this report contain?

  • What was the market size of the U.S. Influenza Vaccines Market in 2020 and the expected market size by 2030, along with the growth rate?
  • An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
  • Which are the largest revenue generating products, services or regions and their comparative growth rate?
  • Which technology is in trend and how would it evolve during the forecast period (2019– 2030)?
  • Which are the leading companies in the U.S. Influenza Vaccines Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

CLIENTS

SHARE YOUR CART